Disorders of carbohydrate-lipid metabolism and galectin-3 level as factors of liver fibrosis progression in chronic hepatitis C

Disorders of carbohydrate-lipid metabolism and galectin-3 level as factors of liver fibrosis progression in chronic hepatitis C

Aim. To assess the effect of metabolic disorders and galectin-3 levels on the progression of liver fibrosis in chronic hepatitis C. Materials and methods. 106 patients with HCV without decompensated liver cirrhosis were examined. Exclusion criteria: age younger than 20 and older than 65 years, di...

Full description

Bibliographic Details
Main Authors:	V. A. Kovalevа, N. S. Zhevnerova, T. V. Antonova
Format:	Article
Language:	Russian
Published:	"Consilium Medicum" Publishing house 2021-02-01
Series:	Терапевтический архив
Subjects:	chronic hepatitis c liver fibrosis abdominal obesity insulin resistance galectin-3
Online Access:	https://ter-arkhiv.ru/0040-3660/article/viewFile/64708/47584

Similar Items

Clinical and laboratory characteristics of chronic hepatitis C on the early stages of development
by: N. S. Zhevnerova, et al.
Published: (2016-12-01)

Role of Galectins in the Liver Diseases: A Systematic Review and Meta-Analysis
by: Yang An, et al.
Published: (2021-10-01)

Galectin 1—A Key Player between Tissue Repair and Fibrosis
by: Anca Hermenean, et al.
Published: (2022-05-01)

Galectin-1 Restores Immune Tolerance to Liver Transplantation Through Activation of Hepatic Stellate Cells
by: Zhi-Jun Jiang, et al.
Published: (2018-07-01)

Hepatic stellate cells contribute to liver regeneration through galectins in hepatic stem cell niche
by: Jian-Yun Ge, et al.
Published: (2020-09-01)

Increased Expression of Galectin-3 in Skin Fibrosis: Evidence from In Vitro and In Vivo Studies
by: Teresa Peiró, et al.
Published: (2022-12-01)

Overexpression of Galectin-1 and Galectin-3 in hepatocellular carcinoma
by: Tahereh Setayesh, et al.
Published: (2020-12-01)

Galectin-3 in heart transplant rejection and fibrosis
by: O. P. Shevchenko, et al.
Published: (2019-10-01)

GALECTIN-3 — BIOMARKER OF FIBROSIS IN PATIENTS WITH METABOLIC SYNDROME
by: O. M. Drapkina, et al.
Published: (2015-09-01)

Galectin-1 in Obesity and Type 2 Diabetes
by: Emanuel Fryk, et al.
Published: (2022-09-01)

Visceral Adiposity Index and the Degree of Hepatic Fibrosis and Inflammation in Egyptian Patients with Chronic Hepatitis C
by: Zainab Ahmed Ali-Eldin, et al.
Published: (2017-08-01)

The impact of hepatitis E infection on hepatic fibrosis in liver transplanted patients for hepatitis C infection
by: Adriano Claudio Pereira de Moraes, et al.
Published: (2021-05-01)

Galectin-3 promotes fibrosis in ovarian endometriosis
by: Guimin Yang, et al.
Published: (2024-02-01)

The characteristics of immune status and carbohydrate metabolism at different stages of liver fibrosis in patients with hepatitis C virus-related chronic hepatitis
by: Yu.M. Stepanov, et al.
Published: (2020-02-01)

Apoptosis and progression of hepatic fibrosis in hepatitis C patients
by: Maria Isabel Schinoni, et al.

Cellular and Molecular Mechanism of Pulmonary Fibrosis Post-COVID-19: Focus on Galectin-1, -3, -8, -9
by: Daniela Oatis, et al.
Published: (2022-07-01)

Macrophages and Galectin 3 Control Bacterial Burden in Acute and Subacute Murine Leptospirosis That Determines Chronic Kidney Fibrosis
by: María F. Ferrer, et al.
Published: (2018-10-01)

Autoimmune Hepatitis and Fibrosis
by: Rinaldo Pellicano, et al.
Published: (2023-03-01)

Morphogenesis of pericellular liver fibrosis in patients with chronic viral hepatitis C associated with hepatic steatosis
by: V. A. Tumanskiy, et al.
Published: (2012-08-01)

Progress of researches on inducing hepatic stellate cell ferroptosis for treatment of liver fibrosis
by: SUN Lijie, HAO Dandan
Published: (2024-01-01)

Galectins Are Central Mediators of Immune Escape in Pancreatic Ductal Adenocarcinoma
by: Zhengting Jiang, et al.
Published: (2022-11-01)

Galectins in epithelial-mesenchymal transition: roles and mechanisms contributing to tissue repair, fibrosis and cancer metastasis
by: Elisa Perez-Moreno, et al.
Published: (2024-04-01)

Role of Galectins in Multiple Myeloma
by: Paola Storti, et al.
Published: (2017-12-01)

Galectin-3 in patients with atrial fibrillation and restored sinus rhythm
by: Antoniya Kisheva, et al.
Published: (2021-06-01)

Galectin-3 Is Associated with Cardiac Fibrosis and an Increased Risk of Sudden Death
by: Mingma D. Sherpa, et al.
Published: (2023-04-01)

The level of galectin-3 in the blood serum of patients with chronic hepatitis C
by: V. A. Kovalevа, et al.
Published: (2016-07-01)

Angiogenesis and experimental hepatic fibrosis
by: Queli Teixeira Lemos, et al.
Published: (2010-08-01)

Hyperinflammation and Fibrosis in Severe COVID-19 Patients: Galectin-3, a Target Molecule to Consider
by: Juan Garcia-Revilla, et al.
Published: (2020-08-01)

Inhibition of galectin-3 ameliorates the consequences of cardiac lipotoxicity in a rat model of diet-induced obesity
by: Gema Marín-Royo, et al.
Published: (2018-02-01)

Prognostic significance of serum galectin-3 levels in patients with hepatocellular cancer and chronic viral hepatitis
by: Mehmet Ulu, et al.
Published: (2015-01-01)

Noninvasive Tests (NITs) for Hepatic Fibrosis in Fatty Liver Syndrome
by: Ma Ai Thanda Han
Published: (2020-09-01)

Abdominal obesity and dsyglycemia are risk factors for liver fibrosis progression in NAFLD subjects: A population-based study
by: María Teresa Julián, et al.
Published: (2023-01-01)

Association between hepatic steatosis and fibrosis with measures of insulin sensitivity in patients with severe obesity and type 2 diabetes - a cross-sectional study
by: Kathrine Aglen Seeberg, et al.
Published: (2022-11-01)

Hepatitis C and insulin resistance: steatosis, fibrosis and non-response Hepatitis C y resistencia a la insulina: esteatosis, fibrosis y no respuesta
by: M. Romero-Gómez
Published: (2006-08-01)

Reliability of Hepatus® for Evaluating Liver Fibrosis in Chronic Hepatitis B
by: Jessica Cynthia Febryani, et al.
Published: (2022-09-01)

Diagnostic Value of Conventional and Doppler Ultrasound Findings in Liver Fibrosis in Patients with Chronic Viral Hepatitis
by: Yasmin Davoudi, et al.
Published: (2015-09-01)

T cells and liver fibrosis
by: Ruonan Sun, et al.
Published: (2022-09-01)

Prevalence and Predictors of Liver Fibrosis in People Living with Hepatitis B in Senegal
by: Adrià Ramírez Mena, et al.
Published: (2022-07-01)

Endometrial regenerative cells with galectin-9 high-expression attenuate experimental autoimmune hepatitis
by: Hongda Wang, et al.
Published: (2021-10-01)

Content of certain cytokines and chemokines in blood ofpatients with chronic hepatitis B in the early stages of liver fibrosis
by: O. K. Batsunov, et al.
Published: (2020-04-01)